TacticScaleWhat Globus Medical Does & How It Makes Money (GMED)
Updated October 2026 · reflects Globus Medical's latest reported financials
Medical device maker of spine, orthopedic implants and surgical robots. It earns revenue by selling spine, trauma and joint-replacement implants, biologics and robotic/navigation systems to hospitals and surgeons through direct sales reps, distributors and independent agents, plus fees for neuromonitoring and spinal cord stimulation services.
How Globus Medical makes money
It earns revenue by selling spine, trauma and joint-replacement implants, biologics and robotic/navigation systems to hospitals and surgeons through direct sales reps, distributors and independent agents, plus fees for neuromonitoring and spinal cord stimulation services.
What Globus Medical does
Globus Medical, Inc. is a musculoskeletal medical device company headquartered in Audubon, Pennsylvania, and incorporated in 2003. Its core is spine: traditional fusion implants such as pedicle screw and rod systems, plates, intervertebral spacers and corpectomy devices, along with motion preservation technologies, treatments for vertebral compression fractures, and biologics like allografts and synthetic bone graft alternatives. It has broadened into orthopedic trauma (plates, nails, external fixation), hip and knee arthroplasty, spinal cord stimulation, and neuromonitoring services. A major part of its offering is enabling technology: the ExcelsiusGPS robotic guidance and navigation system, Excelsius3D intraoperative imaging, ExcelsiusHub, the ExcelsiusFlex knee replacement robot, and Surgimap planning software. These systems pair with its implants to support minimally invasive and open procedures. Globus sells in the U.S. and internationally through direct sales reps, distributors and independent agents.
Products & services
- ExcelsiusGPS robotic navigation system
- Excelsius3D imaging and navigation platform
- ExcelsiusFlex knee arthroplasty robot
- Pedicle screw and rod spinal fusion systems
- Hip and knee arthroplasty implants
- Neuromonitoring services
What is Globus Medical worth?
On an owner-earnings DCF, Globus Medical's most-likely value is about $138 versus a recent price near $75 (85% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$57) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Double Medical Technology (002901.SZ) · Zimmer Biomet (ZBH) · Medtronic (MDT) · Boston Scientific (BSX) · Glaukos (GKOS)